This innovation has enabled us to uncover significant correlations between CDX2 expression patterns and key histopathological parameters, such as tumor budding and differentiation grades, which are instrumental in assessing tumor behavior, thus bolstering the prognostic significance of the CDX2 biomarker in colon cancer. This evidence concerns the gene CDX2 and colonic neoplasm.